April 6, 2017
Barlow starts as CEO at e-Therapeutics
e-Therapeutics, the drug discovery company, announced Thursday that Dr. Raymond Barlow has assumed his position as Chief Executive Officer.
Pharmaceuticals, Biotechnology and Life Sciences
Category: Regions
April 6, 2017
PureTech’s Akili pilot study shows improved cognitive control in children with sensory processing dysfunction and attentional deficits
PureTech Health’s subsidiary Akili announced results from a project EVO pilot study demonstrating improved cognitive control in children with sensory processing dysfunction and attentional deficits.
April 6, 2017
NHS England’s third clinical fellowship scheme
NHS England is now inviting for the 2017 Clinical Fellowship Scheme for practising pharmacists.
April 6, 2017
Scientists discover cure for monkeys infected with viruses related to Ebola
An experimental treatment cured 100 percent of guinea pigs and rhesus monkeys in late stages of infection with lethal levels of Marburg and Ravn viruses, relatives of the Ebola virus.
April 6, 2017
Hikma, Jazz settle for Xyrem patent litigation
Hikma Pharmaceuticals and Jazz Pharmaceuticals have found a mutual language regarding a Jazz’s Xyrem patent litigation.
April 5, 2017
Allecra Therapeutics appoints new Chairman of the Board and CMO
Allecra Therapeutics, a Germany-based clinical-stage biopharmaceutical company dedicated to the development of novel antibiotics to combat drug-resistant bacterial infections, has appointed Dr. Engelbert (Bert) Tjeenk Willink as a Chairman of the Board and Dr. Leon Hooftmanas as Chief Medical Officer.
April 5, 2017
Sanofi welcomes new EVP
Sanofi has appointed Bill Sibold, a current head of Sanofi Genzyme’s Global Multiple Sclerosis, Oncology and Immunology organization, as Executive Vice President Sanofi Genzyme and member of the Executive Committee, effective July 1, 2017.
April 5, 2017
Heptares trigers milestone payment from AstraZeneca
Sosei Group Corporation’s subsidiary Heptares Therapeutics got milestone payment from AstraZeneca for working together on an immuno-oncology project.
April 5, 2017
Abzena raises £25 M to boost its growth
Abzena, a life sciences group providing services and technologies to enable the development and manufacture of biopharmaceutical products, will initiate a placing to raise approximately £25 million to expand further its service offering, capacity and capabilities.
April 5, 2017
Sanofi’s partner JHL Biotech accepted for clinical trial in China
JHL Biotech said Wednesday its Clinical Trial Application (CTA) for use of its first product in pipleine, JHL1101 in Phase 1 and Phase 3 clinical trials in Non-Hodgkin’s Lymphoma patients has been accepted by the China Food and Drug Administration (CFDA).